NCT02489513View on ClinicalTrials.gov

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-AG-120

Labeled investigational drug

Trial Locations (1)

53704

Research Site, Madison

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY